Paper42347697
Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors.
Eberl J and 2 others. Cancer Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors. Papers, record 42347697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42347697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rhabdoid Tumor | Major topic |
| Algorithms | Major topic |
| Humans | |
| SEER Program | |
| Female | |
| Risk Assessment | |
| Nomograms | |
| Prognosis | |
| Male | |
| Child, Preschool | |
| Infant | |
| Child | |
| Adolescent | |
| Risk Factors | |
| Proportional Hazards Models | |
| Survival Rate |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33675698 | Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. | Lancet Child Adolesc Health | 2021 | https://conductscience.org/library/papers/33675698 | PubMed |
| 2 | 34929472 | Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendations. | Eur J Cancer | 2022 | https://conductscience.org/library/papers/34929472 | PubMed |
| 3 | 29208319 | Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. | Eur J Surg Oncol | 2018 | https://conductscience.org/library/papers/29208319 | PubMed |
| 4 | 25370967 | Prognostic factors in soft tissue sarcoma. | Dan Med J | 2014 | https://conductscience.org/library/papers/25370967 | PubMed |
| 5 | 36614077 | The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36614077 | PubMed |
| 6 | 30914466 | Clinical and Prognostic Characteristics of 53 Cases of Extracranial Malignant Rhabdoid Tumor in Children. A Single-Institute Experience from 2007 to 2017. | Oncologist | 2019 | https://conductscience.org/library/papers/30914466 | PubMed |
| 7 | 7275104 | Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. | Hum Pathol | 1981 | https://conductscience.org/library/papers/7275104 | PubMed |
| 8 | 7884423 | The Third Intergroup Rhabdomyosarcoma Study. | J Clin Oncol | 1995 | https://conductscience.org/library/papers/7884423 | PubMed |
| 9 | 15735125 | Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15735125 | PubMed |
| 10 | 25968827 | Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications. | Int J Radiat Oncol Biol Phys | 2015 | https://conductscience.org/library/papers/25968827 | PubMed |
| 11 | 206343 | Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. | Cancer | 1978 | https://conductscience.org/library/papers/206343 | PubMed |
| 12 | 33249395 | Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK). | Eur J Cancer | 2021 | https://conductscience.org/library/papers/33249395 | PubMed |
| 13 | 25846097 | Nomograms in oncology: more than meets the eye. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25846097 | PubMed |
| 14 | 10577841 | Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10577841 | PubMed |
| 15 | 22180295 | Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. | Cancer | 2012 | https://conductscience.org/library/papers/22180295 | PubMed |
| 16 | 12665210 | Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions. | J Cancer Epidemiol Prev | 2002 | https://conductscience.org/library/papers/12665210 | PubMed |
| 17 | 22213196 | Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. | Cancer | 2012 | https://conductscience.org/library/papers/22213196 | PubMed |
| 18 | 24633978 | Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry. | Klin Padiatr | 2014 | https://conductscience.org/library/papers/24633978 | PubMed |
| 19 | 21370404 | Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group. | Pediatr Blood Cancer | 2011 | https://conductscience.org/library/papers/21370404 | PubMed |
| 20 | 3275486 | The Intergroup Rhabdomyosarcoma Study-I. A final report. | Cancer | 1988 | https://conductscience.org/library/papers/3275486 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42347697
GET https://conductscience.org/api/papers/v1/42347697/references?page=2